Paper21397853
SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF.
Schumacker PT. Cancer Cell, 2011. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF. Papers, record 21397853. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21397853
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypoxia-Inducible Factor 1, alpha Subunit | Major topic |
| Neoplasms | Major topic |
| Reactive Oxygen Species | Major topic |
| Sirtuin 3 | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cells, Cultured | |
| Fibroblasts | |
| Glucose | |
| Glycolysis | |
| Humans | |
| Metabolomics | |
| Mice | |
| Mice, Knockout | |
| Models, Biological |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL035440 | NHLBI NIH HHS | United States | R01HL035440 | PubMed and NIH | NIH RePORTER |
| R01 HL079650 | NHLBI NIH HHS | United States | R01HL079650 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 21397863 | SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. | https://conductscience.org/library/papers/21397863 |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9751731 | Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9751731 | PubMed |
| 2 | 18781224 | SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. | Int J Biol Sci | 2008 | https://conductscience.org/library/papers/18781224 | PubMed |
| 3 | 20129246 | SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20129246 | PubMed |
| 4 | 21397863 | SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. | Cancer Cell | 2011 | https://conductscience.org/library/papers/21397863 | PubMed |
| 5 | 19460998 | Understanding the Warburg effect: the metabolic requirements of cell proliferation. | Science | 2009 | https://conductscience.org/library/papers/19460998 | PubMed |
| 6 | 19942427 | HIF-1: upstream and downstream of cancer metabolism. | Curr Opin Genet Dev | 2010 | https://conductscience.org/library/papers/19942427 | PubMed |
| 8 | 20129243 | A tumor suppressor SIRTainty. | Cancer Cell | 2010 | https://conductscience.org/library/papers/20129243 | PubMed |
| 9 | 19946328 | Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. | Oncogene | 2010 | https://conductscience.org/library/papers/19946328 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943315 | Sirtuin Upregulation in the Cochlea During Honokiol-Mediated Protection Against Cisplatin Ototoxicity. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943315 | PubMed |
| 40260844 | Exercise performance in well-trained male mice is promoted by intermittent hyperoxia via improving metabolic properties and capillary profiles. | Physiol Rep | 2025 | https://conductscience.org/library/papers/40260844 | PubMed |
| 38816444 | Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer. | Sci Rep | 2024 | https://conductscience.org/library/papers/38816444 | PubMed |
| 37240068 | Bioinformatics Identification of Regulatory Genes and Mechanism Related to Hypoxia-Induced PD-L1 Inhibitor Resistance in Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240068 | PubMed |
| 36896611 | SIRT3-dependent delactylation of cyclin E2 prevents hepatocellular carcinoma growth. | EMBO Rep | 2023 | https://conductscience.org/library/papers/36896611 | PubMed |
| 36632749 | Hypoxia-induced ROS aggravate tumor progression through HIF-1α-SERPINE1 signaling in glioblastoma. | J Zhejiang Univ Sci B | 2023 | https://conductscience.org/library/papers/36632749 | PubMed |
| 35386222 | Apelin-13 Attenuates Lipopolysaccharide-Induced Inflammatory Responses and Acute Lung Injury by Regulating PFKFB3-Driven Glycolysis Induced by NOX4-Dependent ROS. | J Inflamm Res | 2022 | https://conductscience.org/library/papers/35386222 | PubMed |
| 35136826 | Bioinformatic Analysis of the Effect of the Sirtuin Family on Differentiated Thyroid Carcinoma. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35136826 | PubMed |
| 34841698 | HIF2α promotes tumour growth in clear cell renal cell carcinoma by increasing the expression of NUDT1 to reduce oxidative stress. | Clin Transl Med | 2021 | https://conductscience.org/library/papers/34841698 | PubMed |
| 34748401 | Stress Responses as Master Keys to Epigenomic Changes in Transcriptome and Metabolome for Cancer Etiology and Therapeutics. | Mol Cell Biol | 2022 | https://conductscience.org/library/papers/34748401 | PubMed |
| 33415008 | Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/33415008 | PubMed |
| 33298860 | TGR5 deficiency aggravates hepatic ischemic/reperfusion injury via inhibiting SIRT3/FOXO3/HIF-1ɑ pathway. | Cell Death Discov | 2020 | https://conductscience.org/library/papers/33298860 | PubMed |
| 32781782 | SUMOylation-Mediated Response to Mitochondrial Stress. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32781782 | PubMed |
| 32041310 | Antioxidant and Anti-Proliferative Properties of Hagenia abyssinica Roots and Their Potentially Active Components. | Antioxidants (Basel) | 2020 | https://conductscience.org/library/papers/32041310 | PubMed |
| 32010617 | Role of Sirtuins in Tumor Angiogenesis. | Front Oncol | 2019 | https://conductscience.org/library/papers/32010617 | PubMed |
| 31712596 | Sirtuin 3 deficiency does not impede digit regeneration in mice. | Sci Rep | 2019 | https://conductscience.org/library/papers/31712596 | PubMed |
| 30779316 | Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3-Forkhead box O3a axis in human small-cell lung cancer. | Thorac Cancer | 2019 | https://conductscience.org/library/papers/30779316 | PubMed |
| 30094960 | Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells. | Cancer Med | 2018 | https://conductscience.org/library/papers/30094960 | PubMed |
| 30050455 | Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia. | Front Physiol | 2018 | https://conductscience.org/library/papers/30050455 | PubMed |
| 29800930 | Hydrogen Sulfide Demonstrates Promising Antitumor Efficacy in Gastric Carcinoma by Targeting MGAT5. | Transl Oncol | 2018 | https://conductscience.org/library/papers/29800930 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAT | 847 | PubTator's text mining | https://conductscience.org/library/genes/847 | NCBI Gene |
| FOXO3 | 2309 | PubTator's text mining | https://conductscience.org/library/genes/2309 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| SIRT3 | 23410 | PubTator's text mining | https://conductscience.org/library/genes/23410 | NCBI Gene |
| SOD2 | 6648 | PubTator's text mining | https://conductscience.org/library/genes/6648 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21397853
GET https://conductscience.org/api/papers/v1/21397853/cited_by?page=2